Woodline Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-105,261
| Closed | -$3.95M | – | 671 |
|
|
2024
Q1 | $3.95M | Buy |
+105,261
| New | +$3.95M | 0.04% | 382 |
|
|
2023
Q4 | – | Sell |
-151,098
| Closed | -$6.23M | – | 655 |
|
|
2023
Q3 | $6.23M | Buy |
+151,098
| New | +$6.23M | 0.07% | 284 |
|
|
2023
Q2 | – | Sell |
-61,270
| Closed | -$3.42M | – | 751 |
|
|
2023
Q1 | $3.42M | Sell |
61,270
-142,784
| -70% | -$7.97M | 0.05% | 343 |
|
|
2022
Q4 | $7.44M | Buy |
+204,054
| New | +$7.44M | 0.1% | 256 |
|